Search research articles
Contact Us
Filters
Showing results (71-80 of 135) with videos related to
Page
of 14
Sort By:
European Heart Journal Open
|
August 3, 2022
Long-term outcomes following rheumatic heart disease diagnosis in Australia
Ingrid Stacey, Joseph Hung, Jeff Cannon, et al.
Vaccine
|
June 7, 2016
Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine?
Patrick G Holt, Tom Snelling, Olivia J White, et al.
BMJ Open
|
January 30, 2026
Country-level and global burden of diseases caused by group A <i>Streptococcus:</i> protocol for a multicountry epidemiological study
Belaynew Wasie Taye, Jeffrey Cannon, Chris Van Beneden, et al.
Vaccine
|
April 30, 2017
Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsiveness
Sarah Moberley, Paul V Licciardi, Anne Balloch, et al.
BMC Infectious Diseases
|
July 19, 2019
Understanding group A streptococcal pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective disease incidence study
Julie Bennett, Nicole J Moreland, Jane Oliver, et al.
Australian and New Zealand Journal of Public Health
|
February 7, 2019
High burden of infectious disease and antibiotic use in early life in Australian Aboriginal communities
Will Cuningham, Jodie McVernon, Michael J Lydeamore, et al.
Circulation
|
December 21, 2018
Dysregulated IL-1β-GM-CSF Axis in Acute Rheumatic Fever That Is Limited by Hydroxychloroquine
Man Lyang Kim, William J Martin, Gabriela Minigo, et al.
The Journal of Infection
|
May 16, 2025
High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: A single arm, phase IIa trial of safety and pharmacokinetics
Julie Bennett, Sam Salman, Dhevindri Moodley, et al.
The Lancet. Global Health
|
February 16, 2024
Outcomes of rheumatic fever in Uganda: a prospective cohort study
Scott H Wirth, Jafesi Pulle, JangDong Seo, et al.
The Journal of Antimicrobial Chemotherapy
|
July 13, 2022
Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia
Joseph Kado, Sam Salman, Robert Hand, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 135) with videos related to
Sort By:
Page
of 14
European Heart Journal Open
|
August 3, 2022
Long-term outcomes following rheumatic heart disease diagnosis in Australia
Ingrid Stacey, Joseph Hung, Jeff Cannon, et al.
Vaccine
|
June 7, 2016
Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine?
Patrick G Holt, Tom Snelling, Olivia J White, et al.
BMJ Open
|
January 30, 2026
Country-level and global burden of diseases caused by group A <i>Streptococcus:</i> protocol for a multicountry epidemiological study
Belaynew Wasie Taye, Jeffrey Cannon, Chris Van Beneden, et al.
Vaccine
|
April 30, 2017
Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsiveness
Sarah Moberley, Paul V Licciardi, Anne Balloch, et al.
BMC Infectious Diseases
|
July 19, 2019
Understanding group A streptococcal pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective disease incidence study
Julie Bennett, Nicole J Moreland, Jane Oliver, et al.
Australian and New Zealand Journal of Public Health
|
February 7, 2019
High burden of infectious disease and antibiotic use in early life in Australian Aboriginal communities
Will Cuningham, Jodie McVernon, Michael J Lydeamore, et al.
Circulation
|
December 21, 2018
Dysregulated IL-1β-GM-CSF Axis in Acute Rheumatic Fever That Is Limited by Hydroxychloroquine
Man Lyang Kim, William J Martin, Gabriela Minigo, et al.
The Journal of Infection
|
May 16, 2025
High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: A single arm, phase IIa trial of safety and pharmacokinetics
Julie Bennett, Sam Salman, Dhevindri Moodley, et al.
The Lancet. Global Health
|
February 16, 2024
Outcomes of rheumatic fever in Uganda: a prospective cohort study
Scott H Wirth, Jafesi Pulle, JangDong Seo, et al.
The Journal of Antimicrobial Chemotherapy
|
July 13, 2022
Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia
Joseph Kado, Sam Salman, Robert Hand, et al.
Page
of 14